BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 20489420)

  • 1. Diabetes, prediabetes and cardiovascular risk.
    Mellbin LG; Anselmino M; Rydén L
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S9-14. PubMed ID: 20489420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular prevention in patients with diabetes and prediabetes.
    Anselmino M; Gohlke H; Mellbin L; Rydén L
    Herz; 2008 Apr; 33(3):170-7. PubMed ID: 18568310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials.
    Hopper I; Billah B; Skiba M; Krum H
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):813-23. PubMed ID: 21878448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection and integrated management of dysglycemia in cardiovascular disease: a key factor for decreasing the likelihood of future events.
    Anselmino M; Mellbin L; Wallander M; Rydén L
    Rev Cardiovasc Med; 2008; 9(1):29-38. PubMed ID: 18418307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inadequacies of absolute threshold levels for diagnosing prediabetes.
    Bergman M
    Diabetes Metab Res Rev; 2010 Jan; 26(1):3-6. PubMed ID: 20101658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
    Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
    Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients.
    Charfen MA; Ipp E; Kaji AH; Saleh T; Qazi MF; Lewis RJ
    Acad Emerg Med; 2009 May; 16(5):394-402. PubMed ID: 19302369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control and cardiovascular mortality.
    Riddle MC
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):104-9. PubMed ID: 21522000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal care of cardiovascular disease and type 2 diabetes patients: shared responsibilities between the cardiologist and diabetologist.
    Leiter LA; Fitchett D
    Atheroscler Suppl; 2006 Apr; 7(1):37-42. PubMed ID: 16516560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The links between diabetes and cardiovascular disease.
    Schnell O
    J Interv Cardiol; 2005 Dec; 18(6):413-6. PubMed ID: 16336420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycaemia and cardiovascular disease.
    Bartnik M; Norhammar A; Rydén L
    J Intern Med; 2007 Aug; 262(2):145-56. PubMed ID: 17645583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study to find out the proportion of prediabetes in patients with acute coronary syndrome in a medical college of Kolkata.
    Sen K; Mukherjee AK; Dharchowdhury L; Chatterjee A
    J Indian Med Assoc; 2008 Dec; 106(12):776-8. PubMed ID: 19370946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediabetes: the importance of early identification and intervention.
    Hsueh WA; Orloski L; Wyne K
    Postgrad Med; 2010 Jul; 122(4):129-43. PubMed ID: 20675976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
    Karasik A
    Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediabetes in a nursing facility patient with renal insufficiency.
    Shane-McWhorter L
    Consult Pharm; 2010 Jun; 25 Suppl B():11-8. PubMed ID: 20726378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose perturbations and cardiovascular risk: challenges and opportunities.
    Rydén L; Mellbin L
    Diab Vasc Dis Res; 2012 Jul; 9(3):170-6. PubMed ID: 22752941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
    Roman G; Hancu N
    Horm Metab Res; 2009 Feb; 41(2):116-22. PubMed ID: 19214921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental diabetes, pubertal stage, and extreme obesity are the main risk factors for prediabetes in children and adolescents: a simple risk score to identify children at risk for prediabetes.
    Reinehr T; Wabitsch M; Kleber M; de Sousa G; Denzer C; Toschke AM
    Pediatr Diabetes; 2009 Sep; 10(6):395-400. PubMed ID: 19140901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.